Dose-Escalated High-Precision Radiotherapy: a Method to Overcome Variations in Biology and Radiosensitivity Limiting the Success of Conventional Approaches?

作者: Carsten Nieder , Minesh P. Mehta

DOI: 10.1007/978-3-540-74386-6_20

关键词:

摘要: This chapter addresses the role of radiation dose escalation as a method to increase tumor cell eradication and improve local control thereby survival cancer patients. While treatment can be designed cover whole with homogeneously distributed full-radiation or simultaneously integrated boost defined subvolumes, normal tissue exposure ultimately limits that safely delivered. Exceeding certain thresholds critical structures might result in unacceptable permanent dysfunction sequelae, profound consequences on quality life. With improved methods target volume definition, image-guided external beam radiotherapy, advanced brachytherapy applications, advent proton heavy-ion-beam facilities, possibilities for safe have never been more promising than they are today. Whether such approaches will able overcome substantial variability sensitivity final outcome remains demonstrated sufficiently powered prospective studies. Preliminary experience suggests rates, e.g., limited stage non-small lung, nasopharyngeal, uterine cervix cancers, promising. It important predict which patients treated high-dose alone should receive radiosensitizers, hypoxia-modifying drugs or, general, modifiers response order optimize cure rates.

参考文章(117)
Karen K. Fu, Thomas F. Pajak, Andy Trotti, Christopher U. Jones, Sharon A. Spencer, Theodore L. Phillips, Adam S. Garden, John A. Ridge, Jay S. Cooper, K.Kian Ang, A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 International Journal of Radiation Oncology Biology Physics. ,vol. 48, pp. 7- 16 ,(1999) , 10.1016/S0360-3016(00)00663-5
David P Dearnaley, Matthew R Sydes, John D Graham, Edwin G Aird, David Bottomley, Richard A Cowan, Robert A Huddart, Chakiath C Jose, John HL Matthews, Jeremy Millar, A Rollo Moore, Rachel C Morgan, J Martin Russell, Christopher D Scrase, Richard J Stephens, Isabel Syndikus, Mahesh KB Parmar, Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncology. ,vol. 8, pp. 475- 487 ,(2007) , 10.1016/S1470-2045(07)70143-2
Harm van Tinteren, Otto S Hoekstra, Egbert F Smit, Jan HAM van den Bergh, Ad JM Schreurs, Roland ALM Stallaert, Piet CM van Velthoven, Emile FI Comans, Fred W Diepenhorst, Paul Verboom, Johan C van Mourlk, Pieter E Postmus, Maarten Boers, Gerrit JJ Teule, Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. The Lancet. ,vol. 359, pp. 1388- 1392 ,(2002) , 10.1016/S0140-6736(02)08352-6
Frank B. Zimmermann, Hans Geinitz, Sabine Schill, Anca Grosu, Ulrich Schratzenstaller, Michael Molls, Branislav Jeremic, Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer Lung Cancer. ,vol. 48, pp. 107- 114 ,(2005) , 10.1016/J.LUNGCAN.2004.10.015
C.Clifton Ling, John Humm, Steven Larson, Howard Amols, Zvi Fuks, Steven Leibel, Jason A Koutcher, Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. International Journal of Radiation Oncology Biology Physics. ,vol. 47, pp. 551- 560 ,(2000) , 10.1016/S0360-3016(00)00467-3
Jinka R Sathya, Ian R Davis, Jim A Julian, Qing Guo, Dean Daya, Ian S Dayes, Himu R Lukka, Mark Levine, None, Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. Journal of Clinical Oncology. ,vol. 23, pp. 1192- 1199 ,(2005) , 10.1200/JCO.2005.06.154
Roy Vergis, Catherine M Corbishley, Andrew R Norman, Jaclyn Bartlett, Sameer Jhavar, Michael Borre, Sara Heeboll, Alan Horwich, Robert Huddart, Vincent Khoo, Ros Eeles, Colin Cooper, Matthew Sydes, David Dearnaley, Chris Parker, Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncology. ,vol. 9, pp. 342- 351 ,(2008) , 10.1016/S1470-2045(08)70076-7
To-Wai Leung, Victy Y.W. Wong, Wing-Kin Sze, Collin M.M. Lui, Stewart Y. Tung, High-Dose-Rate Intracavitary Brachytherapy Boost for Early T Stage Nasopharyngeal Carcinoma{PRIVATE} International Journal of Radiation Oncology*Biology*Physics. ,vol. 70, pp. 361- 367 ,(2008) , 10.1016/J.IJROBP.2007.06.078
Eckhart Dühmke, Jeremy Franklin, Michael Pfreundschuh, Susanne Sehlen, Norman Willich, Ursula Rühl, Rolf-Peter Müller, Peter Lukas, Anton Atzinger, Ursula Paulus, Bernd Lathan, Ulrich Rüffer, Markus Sieber, Jürgen Wolf, Andreas Engert, Axel Georgii, Susanne Staar, Richard Herrmann, Maria Beykirch, Hartmut Kirchner, Adelheid Emminger, Richard Greil, Esther Fritsch, Peter Koch, Angelika Drochtert, Oana Brosteanu, Dirk Hasenclever, Markus Loeffler, Volker Diehl, Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin’s Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone Journal of Clinical Oncology. ,vol. 19, pp. 2905- 2914 ,(2001) , 10.1200/JCO.2001.19.11.2905
Hellwig D, Dietlein M, Schwaiger M, Weber Wa, Schicha H, Kirsch Cm, [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer]. Nuklearmedizin-nuclear Medicine. ,vol. 42, pp. 135- 144 ,(2003)